3-[3-(3-CHLORO-PHENYL)-[1,2,4]OXADIAZOL-5-YL]-PROPIONIC ACID, 95.0%, 250mg

ETHYL 2-(1H-IMIDAZOL-1-YL)-2-OXOACETATE, 95.0%, 1g

L-Histidine>99.0%(HPLC)(T)25g

ethyl 4-amino-1H-imidazole-5-carboxylate hydrochloride, 97%, 250mg

Pentafluorobenzyl chloride, 95.0%, 1g

Trimethylsilyl Acrylate (stabilized with BHT)>95.0%(GC)5mL

(R)-2-((6-((3-Amino-5-chlorophenyl)amino)-9-isopropyl-9H-purin-2-yl)amino)-3-methylbutan-1-ol, 97%, 25mg

6-[amino(imino)methyl]-2-naphthyl 4-{[amino(imino)methyl]amino}benzoate dimethanesulfonate, 98.0%, 50mg

(1S,4aS,7aS)-7-(Hydroxymethyl)-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid, 95.0%, 100mg

2,5,6-trimethyl-3-pyridinamine dihydrochloride, 95.0%, 1g

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzenesulfonamide, 95%, 250mg

2-(hydroxymethyl)-1,4-dihydropyridin-4-one, 97%, 1g

(S)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-4-(4-(TERT-BUTOXY)PHENYL)BUTANOIC ACID, 95%, 1g